Here's a preview of all of the dealmaking events you need to know about for the week of May 19th.
The HSR Act expires for British drug company GlaxoSmithKline's $720 million purchase of Sirtis Pharmaceuticals; Draxis Health shareholders will vote on the proposed merger with drug maker Jubilant; and retailers Target, Home Depot, Limited Brands, Gap, and Talbots will report and discuss earnings.
Suzanne Stevens, senior editor of Corporate Dealmaker, joins us this week with a closer look at Talbots' earnings.